US Bancorp’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Buy |
5,223
+1,569
| +43% | +$86.7K | ﹤0.01% | 1824 |
|
|
2025
Q1 | $177K | Buy |
3,654
+1,524
| +72% | +$73.7K | ﹤0.01% | 2075 |
|
|
2024
Q4 | $82.2K | Sell |
2,130
-5,736
| -73% | -$221K | ﹤0.01% | 2487 |
|
|
2024
Q3 | $354K | Sell |
7,866
-701
| -8% | -$31.5K | ﹤0.01% | 1712 |
|
|
2024
Q2 | $297K | Buy |
8,567
+2,281
| +36% | +$79K | ﹤0.01% | 1793 |
|
|
2024
Q1 | $182K | Sell |
6,286
-881
| -12% | -$25.5K | ﹤0.01% | 2055 |
|
|
2023
Q4 | $164K | Sell |
7,167
-2,743
| -28% | -$62.9K | ﹤0.01% | 2106 |
|
|
2023
Q3 | $165K | Buy |
9,910
+9,871
| +25,310% | +$165K | ﹤0.01% | 1913 |
|
|
2023
Q2 | $1.08K | Buy |
+39
| New | +$1.08K | ﹤0.01% | 3762 |
|
|
2022
Q4 | – | Sell |
-1,112
| Closed | -$9K | – | 4226 |
|
|
2022
Q3 | $9K | Buy |
+1,112
| New | +$9K | ﹤0.01% | 3401 |
|
|
2022
Q2 | – | Sell |
-470
| Closed | -$11K | – | 4158 |
|
|
2022
Q1 | $11K | Buy |
470
+192
| +69% | +$4.49K | ﹤0.01% | 3330 |
|
|
2021
Q4 | $10K | Buy |
278
+14
| +5% | +$504 | ﹤0.01% | 3405 |
|
|
2021
Q3 | $4K | Sell |
264
-91
| -26% | -$1.38K | ﹤0.01% | 3690 |
|
|
2021
Q2 | $16K | Hold |
355
| – | – | ﹤0.01% | 3231 |
|
|
2021
Q1 | $9K | Sell |
355
-73
| -17% | -$1.85K | ﹤0.01% | 3313 |
|
|
2020
Q4 | $9K | Buy |
428
+367
| +602% | +$7.72K | ﹤0.01% | 3209 |
|
|
2020
Q3 | $1K | Hold |
61
| – | – | ﹤0.01% | 3547 |
|
|
2020
Q2 | $1K | Buy |
+61
| New | +$1K | ﹤0.01% | 3553 |
|